Drug Safety To Be Topic Of Senate Health Hearings March 1 & 3
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Health Committee will hold hearings on issues related to prescription drug safety March 1 and 3
You may also be interested in...
Drug Safety Legislation Unlikely, BIO CEO Greenwood Says
Trade association's new chief sees no "great case for, or inclination on the part of the Senate leadership...to legislate on this topic." Upcoming Health Committee hearings may persuade senators to withdraw proposed legislation on drug safety issues, Greenwood says.
Post-Marketing Studies For All Products Endorsed By Drug Safety Expert
A mechanism is needed for post-marketing testing of all new drugs, safety expert Gross says during a Drug & Device Dialogue audio conference on the COX-2 advisory committee meeting. FDA “needs more tools” to protect public health, consumer rep Levin argues.
Drug Safety Legislation Unlikely, BIO CEO Greenwood Says
Trade association's new chief sees no "great case for, or inclination on the part of the Senate leadership...to legislate on this topic." Upcoming Health Committee hearings may persuade senators to withdraw proposed legislation on drug safety issues, Greenwood says.